All Posts By

MetGen

Finalistiesittely MetGen Oy: Mukana luomassa biotalouden verkostoja

By News

Finalist Introduction MetGen Oy: Playing a part in creating networks for bioindustry

MetGen develops enzymatic products for biofuels, pulp and paper production. MetGen produces enzymes, which save energy and speed up chemical reactions. The core of the business is to produce enzymes that, unlike the most of natural enzymes, are able to with stand high temperatures and pH-levels. With MetGen’s special technology platform it is possible to produce enzymes in a cost-effective way. The company took part in the Kasvu Open BioChain Growth Track in order to find out what the current situation in bioindustry of Finland is, explains the Sales and Marketing Director of MetGen Oy Harri Niemelä.

“We entered the competition to see whether it is possible to create networks for bio-industry in Finland and to find out whether there are enough specialists in this kind of biocluster. We would also like to join the pilot cluster in Äänekoski. It was definitely worth participating in the Kasvu Open competition! The experts offered us many solid ideas to be carried on. In addition to that, we have enlarged our network within the industry. “

MetGen Oy is the winner of the BioChain Growth Track

Finalistiesittely MetGen Oy: Mukana luomassa biotalouden verkostoja

MetGen Oy valmistaa entsyymejä bioenergia-, sellu- ja paperiteollisuudelle. Tuotannossa entsyymit toimivat biokatalyytteinä, joilla voidaan merkittävästi nopeuttaa kemiallisia reaktioita ja vähentää energian kulutusta. Yrityksen ydinosaamisena on entsyymien kehittäminen siten, että ne kestävät korkeaa lämpötilaa ja pH-pitoisuuksia, joita luontaiset entsyymit eivät välttämättä kestä. MetGen pystyy teknologiansa avulla tuottamaan entsyymit tehokkaasti, eivätkä siten ole niin hintavia kuin yleisesti luullaan. Bioketju Kasvupolulle yritys lähti mukaan tarkastelemaan tämän hetkistä biotalouden tilannetta, kertoo MetGenin myynti- ja markkinointijohtaja Harri Niemelä.

”Lähdimme mukaan tarkastelemaan, onko Suomessa mahdollista saada aikaan konkreettisia biotalouden verkostoja. Halusimme saada selville, olisiko tällaiselle klusterille riittäväsi toimijoita ja tietenkin halusimme olla tässä mukana Äänekosken pilottia ajatellen. Kannatti ehdottomasti lähteä mukaan! Saimme mylläreiltä konkreettisia ideoita ajateltavaksi ja sen lisäksi saimme kasvatettua tärkeää verkostoa.”

MetGen Oy on Bioketju Kasvupolun voittaja

Lähde: kasvuopen.fi

Finnish companies included in two prominent global lists of top cleantech companies

By News

Cleantech Finland member Metgen, along with Finnish companies Ekonor and Visedo, are included in in the list of The Global Cleantech Cluster Association’s Later Stage Award Top 30 semi-finalists. Metgen is features in the Biofuels/ BioEnergy category while Ekonor and Visedo are in the Cleanweb/IT and Transportation categories respectively.

Finnish companies also made it into another prominent clenatech company listing, The Global Cleantech 100 by the Cleantech Group, as Cleantech Finland member Zenrobotics and Eniram were selected among the global list of innovative companies.

The companies included in the Global Cleantech Cluster Association’s 2014 Later Stage Award are judged by a large panel of cleantech venture capitalists, investors and serial entrepreneurs who collectively manage US3.5 billion in cleantech investment. In each category, the companies are seen to be making both broad strides in their global industries as well as working closely with their regional cleantech clusters to build sustainable green economies and jobs.

The GCCA Later Stage Award Top 30 semi-finalists and Top 10 winners are selected from an original pool of 10,000 eligible companies represented by the GCCA’s fifty-two member clusters. Winners in the Later Stage Award categories will be announced in Lausanne, Switzerland on December 3, 2014

The Global Cleantech 100 is a list of the top one hundred private companies in cleantech. The list is collated by combining proprietary Cleantech Group research data, with over eleven thousand nominations and specific input from an expert panel. According to Cleantech Group, the companies included in the list represent the most innovative and promising ideas in cleantech and are the companies best positioned to solve tomorrow’s cleantech challenges.

MetGen named in 2013 Global Cleantech 100

By News

MetGen is named in the prestigious 2013 Global Cleantech 100 list that recognizes the world’s top cleantech companies most likely to make the biggest market impact over the next 5-10 years.

The list is produced by Cleantech Group, a global market intelligence and consulting firm helping executives connect with cleantech innovation.

“It has been an exciting year for our company. We completed an investment round with some of the leading investors in our industry; we improved the performance of our enzymes significantly and have completed industrial trials with various partners. Today’s Global Cleantech 100 announcement confirms that we address unmet industry needs and that we are on the right track,” said Alex Michine, CEO of Metgen.

The 2013 Global Cleantech 100 is derived from Cleantech Group’s own data and research, combined with the weighted qualitative judgments of hundreds of nominations, and the viewpoints of a global 90-person Expert Panel. To qualify for the list, companies must be independent, profitable, cleantech companies that are not listed on any major stock exchange.

“This list celebrates inspiring entrepreneurs, and serves as the industry standard on gauging where innovation is headed across key sectors,” says Sheeraz Haji, CEO of Cleantech Group.

5,864 companies were nominated this year from 60 countries. These companies were weighted and scored to create a shortlist of 300 companies, with the best 100 companies from 18 countries making the cut to the final list.

Emerald Fund III invests in industrial enzyme developer MetGen

By News

Emerald Technology Ventures is pleased to announce the first investment from its new Fund:MetGen Oy, a Finnish industrial biotech company that develops industrial enzyme solutions for the pulp & paper industry and non-food biomass transformation into renewable chemicals and fuels. Emerald joins the Series A financing round which included Sofinnova Partners, Finnish Industry Investment, HST Partners, Finnvera and Cleantech Invest.

Founded by the serial entrepreneurs Alex Michine and Prof. Alex Azhayev in 2006, MetGen developed a proprietary technology platform to modify naturally occurring enzymes. The approach resulted in outstanding catalytic properties for harsh industrial environments. The enzyme solutions allow for significant energy savings in the refining process of pulp & paper production and contribute to significant cost savings in the conversion of non-food biomass into cellulosic sugars for the biofuel and renewable chemicals industry.

Alex Michine, CEO and Founder of the company stated: “We are very proud to welcome such a high caliber investor to our company. Emerald’s deep domain expertise and global industrial network will be an important pillar in supporting our growth.”

“We are very pleased to be on board and support the company on its growth and international expansion plan,” commented Gina Domanig, Managing Partner at Emerald. “MetGen represents an exciting opportunity to serve the fast growing industrial biotech market.“

Philipp Hasler, Investment Director at Emerald, added: “We identified MetGen as a unique opportunity addressing one of the biggest markets in industrial biotech and with product solutions that are complementary to the offerings of the globally leading enzyme companies.” Following the transaction, Mr. Hasler joined the Supervisory Board of MetGen.